Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment

Published:2024-08-02 Issue: Volume: Page:
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Liu Yi-Tong¹^ORCID,Wu He-Liang²,Su Yan-Dong¹,Wang Yi³,Li Yan¹⁴

Affiliation:

1. Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

2. Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, China.

3. Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

4. Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2024.0078

Reference114 articles.

1. The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review

2. Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions

3. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States

4. Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

5. Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP